↓ Skip to main content

Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer

Overview of attention for article published in JNCI: Journal of the National Cancer Institute, March 2019
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer
Published in
JNCI: Journal of the National Cancer Institute, March 2019
DOI 10.1093/jnci/djz032
Pubmed ID
Authors

Rim S Kim, Nan Song, Patrick G Gavin, Roberto Salgado, Hanna Bandos, Zuzana Kos, Giuseppe Floris, Gert G G M Van den Eynden, Sunil Badve, Sandra Demaria, Priya Rastogi, Louis Fehrenbacher, Eleftherios P Mamounas, Sandra M Swain, D Lawrence Wickerham, Joseph P Costantino, Soonmyung Paik, Norman Wolmark, Charles E Geyer, Peter C Lucas, Katherine L Pogue-Geile

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 15%
Student > Master 4 10%
Student > Doctoral Student 2 5%
Student > Bachelor 2 5%
Professor 2 5%
Other 10 25%
Unknown 14 35%
Readers by discipline Count As %
Medicine and Dentistry 13 33%
Biochemistry, Genetics and Molecular Biology 3 8%
Social Sciences 2 5%
Nursing and Health Professions 1 3%
Agricultural and Biological Sciences 1 3%
Other 4 10%
Unknown 16 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2019.
All research outputs
#23,214,800
of 25,870,940 outputs
Outputs from JNCI: Journal of the National Cancer Institute
#7,692
of 7,900 outputs
Outputs of similar age
#321,214
of 366,627 outputs
Outputs of similar age from JNCI: Journal of the National Cancer Institute
#49
of 50 outputs
Altmetric has tracked 25,870,940 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,900 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,627 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.